Human Genetics Driven Drug Discovery for Cardio-Renal & Metabolic Disease
Time: 11:40 am
day: Summit Day 2
Details:
- Exemplifying the value of human genetics for selection of therapeutic targets leading to increased clinical success rates
- Explaining Variant Bio’s differentiated approach and opportunities for partnerships
- Sharing examples of novel approaches (including kidney disease-focused) based on genetic support
